Ron-receptor tyrosine kinase in tumorigenesis and metastasis
about
The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cellsThe Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancerRon receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failureReceptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma.The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancersVariant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines.Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion.Downregulation of Foxc2 enhances apoptosis induced by 5-fluorouracil through activation of MAPK and AKT pathways in colorectal cancer.Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.HIV‑1 downregulates the expression and phosphorylation of receptor tyrosine kinase by targeting the NF‑κB pathway.The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis.Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer.RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer.Upregulation of recepteur d'origine nantais tyrosine kinase and cell invasiveness via early growth response-1 in gastric cancer cells.Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells.Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model.The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) miceThe short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors.
P2860
Q33592512-EB6D6097-E972-4EFA-A483-6F8BB01585A5Q33783151-34985AAE-DA7B-4FAA-9AB4-AEBA41BAC4F4Q33916039-29BC750B-C5DA-4394-A348-25F9325D7112Q34633416-5F888916-7171-4DB4-BEE7-25BE550C90D3Q34765982-908A0284-353E-4599-AC84-8A464D519B31Q35079037-D7B3D9E3-5D83-45EB-B3F6-338E2D264752Q35213365-E29643AF-76CD-4F68-9F2F-50643F2CDDCEQ36524678-E5832BCE-C56E-43C7-B5D8-BF8DE7795C01Q36698670-DB23813A-332E-497B-9008-406C354A53ABQ37190782-7D4A22ED-DA89-4ECF-A996-35CF6BEA3F22Q37308684-E6D38898-8A4C-4208-9F2A-5943CA7380C8Q39298765-7C920036-DE68-4BB4-BF20-3EA019350BA4Q39412662-66C58CEF-D87D-4E0C-BCA6-E275323CFF38Q39440998-1F2739AC-2986-4FD0-9670-3971C9DA3BA6Q39477514-76FABC40-0B04-4292-BCAB-D22BAEE9C2E1Q39869337-2301C6BC-137F-4865-BCF0-B7CCC92535B1Q41814227-BA208EC9-23BE-44D4-8F85-BB526A36C523Q42738854-CC53B3A7-3CCF-40BD-A544-9A218F1E4EAFQ54296229-EE8E1812-1D67-4168-81FE-CB7FBD2BB163
P2860
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
@ast
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
@en
type
label
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
@ast
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
@en
prefLabel
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
@ast
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
@en
P2860
P356
P1433
P1476
Ron-receptor tyrosine kinase in tumorigenesis and metastasis
@en
P2093
Megan N Thobe
Mike A Leonis
P2860
P304
P356
10.2217/14796694.3.4.441
P407
P577
2007-08-01T00:00:00Z